Tyra Share Price

Tyra Share Price

NASDAQ: TYRA | Small Cap | Healthcare
$20.09
+$0.36 (1.82%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Tyra Stock Performance

Open
$19.48
Prev. Close
$19.73
Circuit Range
N/A
Day Range
$19.48 - $20.41
Year Range
$17.42 - $40.42
Volume
17,307
Average Traded
$20.05

Tyra Share Price Today

As of 22 November 2026, Tyra Biosciences, Inc.'s share price is $20.09. The stock opened at $19.48, compared to its previous close of $19.73. During today's trading session, Tyra Biosciences, Inc.'s share price traded between $19.48 and $20.41, with an average price of $19.95. Over the past 52 weeks, the stock has recorded a high of $40.42 and a low of $17.42. In terms of performance, Tyra Biosciences, Inc.'s share price has declined by 39.90% over the last six months and is down 10.93% on a year-on-year basis.

Tyra Share Price Chart

Line chart of the Tyra price trend over the selected period. The price rose overall, ranging from 19.48 to 20.41, ending at 20.09.
$19.48$20.41
L
Show Current Price
H

Tyra Stock Fundamentals & Key Indicators

Market Cap
$1.20B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.45
Revenue (TTM)
$0.00
Return On Equity (TTM)
-24.46%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-52.55%

Tyra Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$33.51-$39.31-$45.56-$51.12
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-17.31%-15.90%-12.20%

Tyra Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$55.33-$69.13-$86.48-$119.95
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-24.94%-25.10%-38.70%

Tyra Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets17.1616.114.198.89
Current Assets265.45347.46211.67257.29
Total Assets282.61363.56225.86266.18
Non Current Liabilities5.345.816.262.65
Current Liabilities18.0914.5915.335.7
Total Liabilities23.4320.4121.68.35
Shareholders' Equity259.18343.15204.26257.83

Tyra Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-95.14-69.77-50.14-50.29
Investing72.46-98.4-144.61-0.56
Financing8.1202.141.540.63

About Tyra

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Tyra Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$21.57
$20.07
-4.79%
Oct 2026
$22.10
$21.08
-3.70%
Sep 2026
$25.11
$21.89
-16.15%
Aug 2026
$30.84
$26.11
-18.22%
Jul 2026
$32.09
$31.92
-0.09%
Jun 2026
$32.50
$31.95
-4.43%
May 2026
$35.38
$33.43
-3.70%
Apr 2026
$39.45
$34.72
-9.38%
Mar 2026
$32.65
$38.31
+14.91%
Feb 2026
$30.68
$33.34
+7.88%
Jan 2026
$26.20
$30.91
+17.78%
Dec 2025
$21.82
$26.24
+16.34%

Tyra Share Price FAQs